Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
16,976 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Clinical presentation of childhood leukaemia: a systematic review and meta-analysis.
Clarke RT, Van den Bruel A, Bankhead C, et al. · Arch Dis Child · 2016Meta-Analysis, Systematic Review
- The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
Issa GC, Aldoss I, DiPersio J, et al. · Nature · 2023Clinical Trial, Phase I, Research Support, N.I.H., Extramural
- MEN1 mutations mediate clinical resistance to menin inhibition.
Perner F, Stein EM, Wenge DV, et al. · Nature · 2023Clinical Trial, Phase I, Research Support, N.I.H., Extramural
- CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial.
Lancet JE, Uy GL, Newell LF, et al. · Lancet Haematol · 2021Clinical Trial, Phase III, Multicenter Study
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Castaigne S, Pautas C, Terré C, et al. · Lancet · 2012Clinical Trial, Phase III, Multicenter Study
- Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis.
Willyanto SE, Alimsjah YA, Tanjaya K, et al. · Ann Med · 2024Systematic Review, Meta-Analysis
- Oral decitabine-cedazuridine in acute myeloid leukaemia.
Bouligny IM, DiNardo CD · Br J Haematol · 2024Randomized Controlled Trial
- Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK, Russell NH, Hills RK, et al. · Lancet Oncol · 2015Clinical Trial, Phase III, Comparative Study
- Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study.
Geissler K, Koristek Z, Del Castillo TB, et al. · Br J Haematol · 2024Randomized Controlled Trial, Multicenter Study
- Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.
Xuan L, Wang Y, Huang F, et al. · Lancet Oncol · 2020Clinical Trial, Phase III, Multicenter Study
- Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Stelljes M, Middeke JM, Bug G, et al. · Lancet Haematol · 2024Clinical Trial, Phase III, Randomized Controlled Trial
- Safety profile of first-line targeted therapies in elderly and/or comorbid chronic lymphocytic leukaemia patients (unfit subpopulation). A systematic review and network meta-analysis.
Stożek-Tutro A, Reczek M, Kawalec P · Crit Rev Oncol Hematol · 2024Systematic Review, Network Meta-Analysis
- Illness representations and psychological outcomes in chronic lymphocytic leukaemia.
Arrato NA, Valentine TR, Byrd JC, et al. · Br J Health Psychol · 2022Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Ibrutinib and rituximab for chronic lymphocytic leukaemia.
Stirrups R · Lancet Oncol · 2019Clinical Trial, Phase III, Randomized Controlled Trial
- Cutaneous fusarium disease and leukaemias: A systematic review.
Cortés-López PN, Guzmán-Montijo E, Fuentes-Venado CE, et al. · Mycoses · 2024Systematic Review
- Management of adult acute myelogenous leukaemia.
Crowther D, Powles RL, Bateman CJ, et al. · Br Med J · 1973Clinical Trial, Comparative Study
- Ubiquitin-specific proteases (USPs) in leukemia: a systematic review.
Zangooie A, Tavoosi S, Arabhosseini M, et al. · BMC Cancer · 2024Systematic Review
- Immunotherapy for acute myelogenous leukaemia.
Powles RL, Crowther D, Bateman CJ, et al. · Br J Cancer · 1973Clinical Trial, Randomized Controlled Trial
- Maternal Infection in Pregnancy and Childhood Leukemia: A Systematic Review and Meta-analysis.
He JR, Ramakrishnan R, Hirst JE, et al. · J Pediatr · 2020Meta-Analysis, Research Support, Non-U.S. Gov't
- BCG therapy in acute non lymphoid leukaemias.
Vuvan H, Fiere D, Doillon M, et al. · Scand J Haematol · 1978Clinical Trial, Randomized Controlled Trial
- Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis.
Cao HY, Wan CL, Xue SL · Ann Hematol · 2023Systematic Review, Network Meta-Analysis
- Evaluating continuous nursing for elderly patients undergoing leukaemia chemotherapy.
Chen B, Wang J, Shen X · J Pak Med Assoc · 2025Randomized Controlled Trial
- A multi-state model approach for prediction in chronic myeloid leukaemia.
Lauseker M, Hasford J, Hoffmann VS, et al. · Ann Hematol · 2015Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Basophils in acute myeloid leukaemia.
Hoyle CF, Sherrington PD, Fischer P, et al. · J Clin Pathol · 1989Clinical Trial, Research Support, Non-U.S. Gov't
- Spotlight on histamine dihydrochloride in acute myeloid leukaemia.
Yang LP, Perry CM · Drugs Aging · 2011Clinical Trial, Phase III, Multicenter Study
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.